Results 101 to 110 of about 26,046 (277)
Antiarrhythmic Treatment in Heart Failure
<jats:title>Abstract </jats:title><jats:sec> <jats:title>Purpose of Review</jats:title> <jats:p>Arrhythmias are common in patients with heart failure (HF) and are associated with a ...
Eckardt, Lars +4 more
core +1 more source
ABSTRACT Background While various pulsed field ablation (PFA) systems for atrial fibrillation (AF) ablation have become available in recent years, data comparing long‐term efficacy outcomes remain limited. Purpose To compare long‐term efficacy outcomes of two commercially available PFA systems to perform pulmonary vein isolation (PVI) for AF in a ...
Marisa van der Graaf +18 more
wiley +1 more source
New possibilities of antiarrhythmic therapy of atrial fibrillation: A review
Atrial fibrillation (AF) is the most common heart rhythm disorder. According to current recommendations, the treatment of AF includes 3 main directions: "A" – the appointment of anticoagulant therapy with an increased risk of thromboembolic complications,
Aida I. Tarzimanova, Alena Iu. Isaeva
doaj +1 more source
Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development. [PDF]
Seibertz F +24 more
europepmc +1 more source
Eleven consecutive patients with idiopathic dilated cardiomyopathy and spontaneous, sustained ventricular tachycardia (VT) of uniform morphology underwent programmed ventricular stimulation and serial antiarrhythmic drug testing.
H L Waxman +5 more
core +1 more source
Displays bar graphs showing outcome rates stratified by clinical and hemodynamic variables. Asterisks (*) denote statistically significant differences (p ≤ 0.05). “NS” indicates non‐significant comparisons. Percentages are shown above each bar. The top panel corresponds to acute kidney injury (blue bars), and the bottom panel corresponds to acute ...
Tess Calcagno +23 more
wiley +1 more source
Antiarrhythmic drug therapy to treat atrial fibrillation.
Tijekom zadnjih 10 godina uložen je značajan trud u utvrđivanju uloge antiaritmičkog liječenja za održavanje sinusnog ritma kod pacijenata s fibrilacijom atrija (FA). Podaci randomiziranih kontroliranih studija su pokazali da strategija kontrole ritma, u
Dubravko Petrač, Petrač, Dubravko
core
Therapeutic effectiveness of antiarrhythmic agents, defined as the prevention of lethal or potentially lethal arrhythmias, must incorporate considerations of 3 elements: the forms and/or frequency of chronic ventricular arrhythmias, as well as the ...
Kessler, Kenneth M +5 more
core +1 more source
ABSTRACT Ulcerative colitis (UC) and Crohn's disease (CD) are increasingly prevalent in the Asia Pacific region, necessitating updated, region‐specific guidance on advanced therapies. Targeted small molecule agents, such as filgotinib, tofacitinib, upadacitinib, etrasimod, and ozanimod; and the IL‐23 p19 inhibitors (guselkumab, mirikizumab ...
Choon Jin Ooi +34 more
wiley +1 more source
Background Catheter ablation and antiarrhythmic drug therapy are utilized for rhythm control in atrial fibrillation (AF), but their comparative effectiveness, especially with contemporary treatment modalities, remains undefined. We conducted a systematic
Subhash Chander +13 more
doaj +1 more source

